The Kaplan–Meier survival analysis further showed that overall survival was decreased in paediatric neuroblastoma patients with high CCNE1, CDK2 or CHEK2 expression (Fig. 3b and Supplementary Fig. 4). The gene discussed is CDK2; the disease is neuroblastoma.